RNAC logo

Cartesian Therapeutics (RNAC) Total Liabilities

Annual Total Liabilities

$745.23 M
+$673.18 M+934.21%

31 December 2023

RNAC Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$454.56 M
+$5.37 M+1.20%

01 September 2024

RNAC Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RNAC Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+934.2%+894.6%
3 y3 years+442.5%+230.9%
5 y5 years+717.4%+398.6%

RNAC Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+934.2%-39.0%+894.6%
5 y5 yearsat high+1393.5%-39.0%+922.4%
alltimeall timeat high+2069.9%-39.0%+2135.3%

Cartesian Therapeutics Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$454.56 M(+1.2%)
June 2024
-
$449.20 M(+1.6%)
Mar 2024
-
$442.01 M(-40.7%)
Dec 2023
$745.23 M(+934.2%)
$745.23 M(+1530.5%)
Sept 2023
-
$45.70 M(-38.3%)
June 2023
-
$74.06 M(-8.7%)
Mar 2023
-
$81.11 M(+12.6%)
Dec 2022
$72.06 M(-47.5%)
-
Dec 2022
-
$72.06 M(-22.8%)
Sept 2022
-
$93.36 M(-5.2%)
June 2022
-
$98.46 M(+9.5%)
Mar 2022
-
$89.93 M(-34.5%)
Dec 2021
$137.36 M(-25.1%)
$137.36 M(-26.1%)
Sept 2021
-
$185.89 M(+0.6%)
June 2021
-
$184.74 M(-5.9%)
Mar 2021
-
$196.32 M(+7.0%)
Dec 2020
$183.44 M
$183.44 M(-2.6%)
Sept 2020
-
$188.38 M(+113.4%)
June 2020
-
$88.26 M(-9.5%)
DateAnnualQuarterly
Mar 2020
-
$97.56 M(+7.0%)
Dec 2019
$91.17 M(+82.7%)
$91.17 M(+105.1%)
Sept 2019
-
$44.46 M(-5.2%)
June 2019
-
$46.89 M(-1.6%)
Mar 2019
-
$47.66 M(-4.5%)
Dec 2018
$49.90 M(+1.2%)
$49.90 M(-0.8%)
Sept 2018
-
$50.32 M(+2.3%)
June 2018
-
$49.17 M(+1.7%)
Mar 2018
-
$48.35 M(-1.9%)
Dec 2017
$49.29 M(+43.5%)
$49.29 M(+10.4%)
Sept 2017
-
$44.65 M(+14.9%)
June 2017
-
$38.84 M(+18.5%)
Mar 2017
-
$32.77 M(-4.6%)
Dec 2016
$34.34 M(-78.4%)
$34.34 M(+68.9%)
Sept 2016
-
$20.34 M(-9.8%)
June 2016
-
$22.54 M(+10.6%)
Mar 2016
-
$20.38 M(-87.2%)
Dec 2015
$159.32 M(+44.9%)
$159.32 M
Dec 2014
$109.98 M
-

FAQ

  • What is Cartesian Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Cartesian Therapeutics?
  • What is Cartesian Therapeutics annual total liabilities year-on-year change?
  • What is Cartesian Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Cartesian Therapeutics?
  • What is Cartesian Therapeutics quarterly total liabilities year-on-year change?

What is Cartesian Therapeutics annual total liabilities?

The current annual total liabilities of RNAC is $745.23 M

What is the all time high annual total liabilities for Cartesian Therapeutics?

Cartesian Therapeutics all-time high annual total liabilities is $745.23 M

What is Cartesian Therapeutics annual total liabilities year-on-year change?

Over the past year, RNAC annual total liabilities has changed by +$673.18 M (+934.21%)

What is Cartesian Therapeutics quarterly total liabilities?

The current quarterly total liabilities of RNAC is $454.56 M

What is the all time high quarterly total liabilities for Cartesian Therapeutics?

Cartesian Therapeutics all-time high quarterly total liabilities is $745.23 M

What is Cartesian Therapeutics quarterly total liabilities year-on-year change?

Over the past year, RNAC quarterly total liabilities has changed by +$408.86 M (+894.56%)